<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Cell</journal-id><journal-id journal-id-type="iso-abbrev">Microb Cell</journal-id><journal-id journal-id-type="pmc">Microb Cell</journal-id><journal-id journal-id-type="publisher-id">Microb Cell</journal-id><journal-title-group><journal-title>Microbial Cell</journal-title></journal-title-group><issn pub-type="epub">2311-2638</issn><publisher><publisher-name>Shared Science Publishers OG</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5349022</article-id><article-id pub-id-type="doi">10.15698/mic2016.03.485</article-id><article-id pub-id-type="publisher-id">MIC0175E177</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group subj-group-type="heading"><subject>Applied Microbiology</subject></subj-group></subj-group><subj-group><subject>Molecular Biology</subject><subj-group><subject>Genetics</subject></subj-group></subj-group></article-categories><title-group><article-title>Towards understanding the gliotoxin detoxification mechanism:
<italic>in vivo</italic> thiomethylation protects yeast from gliotoxin
cytotoxicity</article-title><alt-title alt-title-type="running-head">Glyotoxin detoxification in
yeast</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Elizabeth B.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dolan</surname><given-names>Stephen K.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fitzpatrick</surname><given-names>David A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Doyle</surname><given-names>Sean</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Gary W.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Biology, Maynooth University, Maynooth, County
Kildare, Ireland. </aff><author-notes><corresp id="cor1">* E-mail: <email>gary.jones@nuim.ie </email></corresp><fn fn-type="COI-statement"><p>Conflict of interest: The authors declare no existing conflicts of
interest.</p></fn><fn><p>Please cite this article as: Elizabeth B. Smith, Stephen K. Dolan, David A.
Fitzpatrick, Sean Doyle and Gary W. Jones (2016). Towards understanding the
gliotoxin detoxification mechanism: <italic>in vivo </italic>thiomethylation
protects yeast from gliotoxin cytotoxicity. <bold>Microbial Cell</bold>
3(3): 120-125. doi: 10.15698/mic2016.03.485</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>2</month><year>2016</year></pub-date><pub-date date-type="collection" publication-format="electronic"><day>07</day><month>3</month><year>2016</year></pub-date><volume>3</volume><issue>3</issue><fpage>120</fpage><lpage>125</lpage><history><date date-type="received" iso-8601-date="20000530"><day>09</day><month>9</month><year iso-8601-date="2000">2015</year></date><date date-type="accepted" iso-8601-date="20010627"><day>07</day><month>1</month><year iso-8601-date="2001">2016</year></date></history><permissions><copyright-year>2016</copyright-year><copyright-holder>Smith et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article released under the terms of the
Creative Commons Attribution (CC BY) license, which allows the unrestricted
use, distribution, and reproduction in any medium, provided the original
author and source are acknowledged.</license-p></license></permissions><abstract><p>Gliotoxin (GT) is a mycotoxin produced by some species of ascomycete fungi
including the opportunistic human pathogen <italic>Aspergillus
fumigatus</italic>. In order to produce GT the host organism needs to have
evolved a self-protection mechanism. GT contains a redox-cycling disulfide
bridge that is important in mediating toxicity. Recently is has been
demonstrated that <italic>A. fumigatus</italic> possesses a novel
thiomethyltransferase protein called GtmA that has the ability to thiomethylate
GT <italic>in vivo</italic>, which aids the organism in regulating GT
biosynthesis. It has been suggested that thiomethylation of GT and similar
sulfur-containing toxins may play a role in providing self-protection in host
organisms. In this work we have engineered <italic>Saccharomyces
cerevisiae</italic>, a GT-na&#x000ef;ve organism, to express <italic>A.
fumigatus</italic> GtmA. We demonstrate that GtmA can readily thiomethylate
GT in yeast, which results in protection of the organism from exogenous GT. Our
work has implications for understanding the evolution of GT self-protection
mechanisms in organisms that are GT producers and non-producers.</p></abstract><kwd-group><kwd>gliotoxin</kwd><kwd>Aspergillus fumigatus</kwd><kwd>Saccharomyces cerevisiae</kwd><kwd>oxidoreductase GliT</kwd><kwd>thio-methyltransferase GtmA</kwd></kwd-group><funding-group><funding-statement>This work was funded by a Science Foundation Ireland Principal
Investigator Award to SD and collaborator GWJ (PI/11/1188). GWJ has been
supported by Science Foundation Ireland grant RFP08/BMT/1439. SKD is a recipient
of an Irish Research Council Embark PhD Fellowship. LC-MS facilities were funded
by the Irish Higher Education Authority. </funding-statement></funding-group></article-meta></front><body><sec sec-type="Introduction"><title>INTRODUCTION</title><p>Gliotoxin (GT) is a fungal natural product with known antibiotic and antifungal
properties and is biosynthesized by the opportunistic human pathogen,
<italic>Aspergillus fumigatus</italic>, as well as by related ascomycetes <xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref>. Gliotoxin biosynthesis is encoded by the
<italic>gli</italic> gene cluster, which contains 13 genes, and the function of
most of these genes has now been elucidated <xref rid="B4" ref-type="bibr">4</xref>.
Effectively, GT is the prototypic epipolythiodioxopiperazine (ETP) and is
structurally and functionally related to a range of disulfide bridge-containing
non-ribosomal peptides including, amongst others, sporidesmin A and sirodesmin <xref rid="B2" ref-type="bibr">2</xref><xref rid="B5" ref-type="bibr">5</xref>. GT is
redox-active; thus, cycling between the oxidized and reduced dithiol form
(GT-(SH)<sub>2</sub>) can generate reactive oxygen species, which have
deleterious cellular effects. GT auto-induces its own biosynthesis by activating and
maintaining <italic>gli</italic> cluster expression <xref rid="B6" ref-type="bibr">6</xref>. In animal cells, GT can inactivate selected protein functionality by
covalent interaction with protein thiols and also deplete cellular glutathione (GSH)
<xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref>.
Indeed, the cytotoxicity of GT is such that an independently regulated gene within
the <italic>gli</italic> cluster, <italic>gliT</italic> encodes GT oxidoreductase
which recognizes GT-(SH)<sub>2</sub> and catalyzes disulfide bridge closure and is
essential in <italic>A. fumigatus</italic> for self-protection against exogenous GT
<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B11" ref-type="bibr">11</xref>.</p><p>GT is not biosynthesized by <italic>Saccharomyces cerevisiae</italic> (baker&#x02019;s
yeast). As a consequence, no endogenous protection system against GT exists in this
species and <italic>S. cerevisiae</italic> growth can be inhibited by exposure to GT
<xref rid="B10" ref-type="bibr">10</xref><xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref>. Expression of the
<italic>A. fumigatus</italic>
<italic>gliT</italic>-mediated self-protection system in yeast has been shown to
confer GT resistance, as has deletion of <italic>GSH1</italic>, responsible for GSH
biosynthesis <xref rid="B10" ref-type="bibr">10</xref><xref rid="B12" ref-type="bibr">12</xref>. Thus, by enabling disulfide bridge closure, preventing the
GSH-mediated chemical reduction of exogenously-added GT to GT-(SH)<sub>2 </sub>or
facilitating GT efflux, the resistance of gliotoxin-na&#x000ef;ve species to this
redox-active molecular species can be augmented.</p><p>Gliotoxin<italic> bis</italic>-thiomethyltransferase (GtmA), the first
<italic>bis</italic> thiomethyltransferase so far identified in any species, has
recently been described in <italic>A. fumigatus</italic> and it has been shown to
convert GT-(SH)<sub>2</sub> to bisdethiobis(methylthio)gliotoxin (BmGT) (Figure 1)
<xref rid="B14" ref-type="bibr">14</xref>. GtmA has also been contemporaneously
characterized by others, where it is referred to as TmtA <xref rid="B15" ref-type="bibr">15</xref>. Interestingly, although GtmA is encoded outside the
<italic>gli</italic> cluster, its expression is induced by GT and it has been
convincingly demonstrated to dissipate GT levels thereby attenuating
<italic>gli</italic> cluster activity and concomitant GT biosynthesis <xref rid="B14" ref-type="bibr">14</xref>. In effect, GtmA appears to be the
&#x02018;off-switch&#x02019; for GT biosynthesis in <italic>A. fumigatus</italic>. Although an
unidentified thiomethyltransferase has been shown to confer resistance to a
bacterial non-ribosomal peptide, holomycin, in<italic> Streptomyces
clavivulgaris</italic>
<xref rid="B16" ref-type="bibr">16</xref>, <italic>gtmA</italic> deletion has
effectively no impact on the sensitivity of <italic>A. fumigatus</italic> to GT
<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref>.</p><fig id="Fig1" orientation="portrait" position="anchor"><label>Figure 1</label><caption><title>FIGURE 1: Conversion of reduced GT to BmGT is mediated by GtmA protein. </title><p>Reduced GT undergoes <italic>bis</italic>-thiomethylation via the action of
GtmA protein and requires two molecules of SAM for the reaction to reach
completion <xref rid="B14" ref-type="bibr">14</xref>. Consequently two
molecules of SAH are produced that re-enter the methyl-methionine cycle
<xref rid="B17" ref-type="bibr">17</xref>. </p></caption><graphic xlink:href="mic-03-120-g01"/></fig><p>Expression of <italic>gtmA</italic> in <italic>S. cerevisiae</italic> was therefore
undertaken to further investigate the functionality of this enzyme and to explore
the hypothesis that, in the absence of concomitant GT biosynthesis and a<italic>
gliT</italic>-mediated self-protection system, GtmA could confer resistance to
GT via BmGT formation.</p></sec><sec><title>RESULTS AND DISCUSSION</title><sec><title>Expression of <italic>gtmA</italic> in yeast increases resistance to
gliotoxin</title><p>While it has been clearly demonstrated that GliT provides the primary
self-protection mechanism against GT in <italic>A.</italic>
<italic>fumigatus</italic>
<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>
and that the production of BmGT via GtmA is primarily linked to GT biosynthesis
and regulation <xref rid="B14" ref-type="bibr">14</xref>, given that the
production of BmGT will nullify GT ability to redox cycle, we hypothesized that
under certain biological conditions GtmA may be able to provide direct
protection against GT toxicity. In previous work from our group and others <xref rid="B10" ref-type="bibr">10</xref><xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref> yeast was utilized as a
tool to explore the <italic>in vivo</italic> effects of exposure to GT.
Following cloning of <italic>gtmA</italic> under control of the constitutive
<italic>SSA2</italic> promoter we demonstrated that <italic>gtmA</italic> is
well expressed in yeast (Figure 2A). Growth of yeast is severely impaired on
medium containing gliotoxin (8 and 16 &#x003bc;g/mL, respectively), but expression of
<italic>gtmA</italic> in yeast provides protection against this cytotoxicity
(Figure 2B). The level of protection provided to yeast by <italic>gtmA</italic>
is more prominent than that provided by <italic>gliT</italic> expression (Figure
2B). Additionally, the level of protection provided when both
<italic>gliT</italic> and <italic>gtmA</italic> are expressed in yeast is
comparable to <italic>gtmA</italic> expression alone, which reflects the
apparent more efficient GT detoxification of GtmA compared to GliT when
engineered in yeast. The expression of both <italic>gtmA</italic> and
<italic>gliT</italic> does not allow yeast to efficiently grow on GT
concentration above those used in this study [data not show]. Expression of the
other methyltransferases encoded within the <italic>gli</italic>-cluster,
<italic>gliM</italic> and <italic>gliN</italic>
<xref rid="B15" ref-type="bibr">15</xref>, did not provide any protection in
yeast against GT toxicity (data not shown).</p><fig id="Fig2" orientation="portrait" position="anchor"><label>Figure 2</label><caption><title>FIGURE 2: Expression of <italic>gtmA</italic> in yeast protects
against GT cytotoxicity.</title><p><bold>(A)</bold> RT-PCR demonstrating that <italic>gtmA</italic> mRNA is
stably expressed in yeast. Yeast <italic>ERG9</italic> mRNA production
is shown as a positive control. </p><p><bold>(B)</bold> Expression of <italic>A. fumigatus</italic> genes
<italic>gtmA</italic> or <italic>gliT</italic> in yeast provides
protection against GT cytotoxicity.</p></caption><graphic xlink:href="mic-03-120-g02"/></fig></sec><sec><title>Expression of <italic>gtmA</italic> in yeast causes BmGT formation from
exogenously-added gliotoxin</title><p>Yeast does not contain an ortholog or homolog of <italic>A. fumigatus
gtmA</italic>
<xref rid="B14" ref-type="bibr">14</xref>. Consequently it is not surprising
that we have never detected the production of BmGT in yeast following exposure
to GT (Figure 3A and Figure 4A). The expression of <italic>gtmA</italic> in
yeast provides this GT-na&#x000ef;ve organism with the capability of converting GT to
BmGT (Figure 3B). The production of BmGT in yeast expressing
<italic>gtmA</italic> is as a result of utilizing exogenous GT as a
substrate (Figure 4B).</p><fig id="Fig3" orientation="portrait" position="anchor"><label>Figure 3</label><caption><title>FIGURE 3: Detection and monitoring of GT and BmGT in yeast using mass
spectrometry.</title><p><bold>(A)</bold> GT is readily detected in supernatants of yeast cells
exposed to exogenous GT. </p><p><bold>(B)</bold> BmGT can only be detected in supernatants from yeast
cells, which express <italic>gtmA</italic>, following exposure to
exogenous GT.</p></caption><graphic xlink:href="mic-03-120-g03"/></fig></sec><sec><title>Biological relevance for gliotoxin conversion to BmGT </title><p>What is the biological significance for GT to BmGT conversion? The results we
present here clearly show that GT conversion to BmGT protects against
cytotoxicity and therefore appear to support the suggestion that thiomethylation
of GT is a protection mechanism, perhaps from exogenous and/or endogenously
produced GT. However, to uncover the true biological relevance of GT to BmGT
conversion we need to consider this reaction in the context of organisms that
produce GT and those that do not. Recent evidence has clearly shown that
deletion of <italic>gtmA</italic>, and hence the removal of the ability to
convert GT to BmGT, in <italic>A. fumigatus </italic>does not produce a
GT-sensitive phenotype <xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref>. This is due to the maintenance of a
fully functional, primary detoxification system, GliT, in a
<italic>gtmA</italic> deletion strain. Furthermore, it has recently been
demonstrated that GliT functions in conjunction with the GT-specific transporter
GliA to maintain intracellular GT at a level that is not toxic to the host cell
<xref rid="B18" ref-type="bibr">18</xref>. The production of BmGT in
<italic>A. fumigatus</italic> facilitates the secretion of this product in a
GliA independent manner <xref rid="B18" ref-type="bibr">18</xref>. The secretion
of BmGT from fungal cells most likely occurs through a non-specific mechanism as
the molecule is efficiently secreted from yeast (this study) and from
GliA-deficient <italic>A. fumigatus</italic>
<xref rid="B18" ref-type="bibr">18</xref>. Thus the primary physiological
relevance of converting GT to BmGT in GT-producing organisms appears to be as a
negative regulator of GT biosynthesis, followed by secretion of the inactive
thiomethylated derivative <xref rid="B18" ref-type="bibr">18</xref>. However,
the <italic>in vivo</italic> consequence of GtmA activity, and consequent BmGT
production and secretion, will depend upon whether an organism is a GT producer
or not.</p><fig id="Fig4" orientation="portrait" position="anchor"><label>Figure 4</label><caption><title>FIGURE 4: Conversion of GT to BmGT over time in yeast expressing
GtmA.</title><p><bold>(A)</bold> BmGT is not detected in supernatants of yeast cells
exposed to exogenous GT over 3 h exposure. </p><p><bold>(B)</bold> BmGT is readily detected in supernatants from yeast
cells expressing <italic>gtmA</italic>. Increased levels of BmGT can be
detected over a 3-hour time period and correlate with a diminution GT
levels.</p></caption><graphic xlink:href="mic-03-120-g04"/></fig><p>Here we clearly show that engineering a GT to BmGT conversion mechanism into a GT
na&#x000ef;ve organism, such as yeast, can provide efficient protection against
exogenous GT (Figures 2, 3 and 4). The yeast genome does not encode for any GtmA
homologs and does not endogenously convert GT to BmGT (Figure 3). Previous
phylogenetic analysis identified organisms within the fungal kingdom that
possess GtmA homologs <xref rid="B14" ref-type="bibr">14</xref> and the
implications from the results of this study suggest that a GT non-producing
organism that possesses a GtmA homolog may well utilize such a protein as a
defense mechanism against GT exposure. The absence of GT production in such
organisms may suggest that from an evolutionary perspective such GtmA homologs
may have evolved to carry out other GT-independent functions in the cell and, if
they possess the ability to produce BmGT, this may not be the primary function
of the protein. Conversely, GT non-producing fungi may have retained GtmA
homologs as a means of occupying the same habitats as GT-producing fungi.</p><p>Moreover, the possibility does exist that GtmA homologs in GT na&#x000ef;ve fungi
constitute an ancient ETP generic-defense mechanism that has allowed the
acquisition and development of the GT-producing gene cluster, or other ETP
clusters. The evolution of the primary detoxification system involving GliT and
GliA, in conjunction with the presence of GtmA, has then allowed for intricate
systems-level interactions to develop in organisms such as <italic>A.
fumigatus</italic>, as recently shown for GT biosynthesis and interplay with
the methyl/methionine cycle <xref rid="B18" ref-type="bibr">18</xref> and for
regulation of the <italic>gli</italic>-cluster itself <xref rid="B14" ref-type="bibr">14</xref>. Any effect upon GT sensitivity of removing the GT to
BmGT conversion system in <italic>A. fumigatus</italic>, or any GT-producing
organism, may only become apparent when undertaken along with the concomitant
abrogation of the primary GT-protection mechanism from the organism. Support for
this hypothesis comes from the recent discovery that deletion of the
<italic>gtmA</italic> homolog in GT-na&#x000ef;ve <italic>Aspergillus niger</italic>
results in sensitivity to exogenously added GT <xref rid="B19" ref-type="bibr">19</xref>.</p></sec></sec><sec sec-type="Material-and-methods "><title>Materials and Methods</title><sec><title>Yeast strains, plasmids and genetic methods</title><p>The <italic>S. cerevisiae</italic> strain used in this study was BY4741
(<italic>MATa; his3</italic>&#x00394;<italic> 1; leu2</italic>&#x00394;<italic> 0;
met15</italic>&#x00394;<italic> 0; ura3</italic>&#x00394;<italic> 0</italic>) and was
obtained from Euroscarf. All media used were as previously described by <xref rid="B20" ref-type="bibr">20</xref>. Cultures were grown at 30&#x000b0;C with
shaking at 200 rpm.</p><p>To observe the effects of <italic>gtmA </italic>expression in <italic>S.
cerevisiae, gtmA </italic>was amplified from <italic>A. fumigatus</italic>
cDNA (ATCC26933) using primers gtmA F and gtmA R (Table 1) and cloned into the
yeast shuttle vector pC210 as previously described by <xref rid="B10" ref-type="bibr">10</xref>. Briefly, primers were designed that incorporated
<italic>NdeI</italic> and <italic>SphI </italic>restriction sites. Following
PCR amplification of the <italic>gtmA </italic>gene, digestion of the
<italic>gtmA </italic>PCR product and of pC210 was carried out followed by
ligation using T4 DNA ligases (Promega) according to manufacturer&#x02019;s instructions
to create pC210-gtmA. Cloning of the <italic>gtmA</italic> fragment and
construct were confirmed using Sanger sequencing.</p><table-wrap id="Tab1" orientation="portrait" position="anchor"><label>Table 1</label><caption><p>Oligonucleotide primers used in this study.</p></caption><table frame="box" rules="groups"><thead><tr><td style="text-align:left background:#EAF1DD" rowspan="1" colspan="1"><bold>Primer
Name</bold></td><td style="text-align:left background:#EAF1DD" rowspan="1" colspan="1"><bold>Sequence
5&#x02019;-3&#x02019;</bold></td></tr></thead><tbody><tr><td style="text-align:left" rowspan="1" colspan="1">gtmA F</td><td style="text-align:left" rowspan="1" colspan="1">AAAAAACATATGATGTCCAAGTCAGACTACATCCAG</td></tr><tr><td style="text-align:left" rowspan="1" colspan="1">gtmA R</td><td style="text-align:left" rowspan="1" colspan="1">AAAAAAGCATGCCTAGGGCTTGAGGCCGGTTG</td></tr><tr><td style="text-align:left" rowspan="1" colspan="1">ERG9 INTERAL F</td><td style="text-align:left" rowspan="1" colspan="1">GACTTATTTGGCCGGTATCCACG</td></tr><tr><td style="text-align:left" rowspan="1" colspan="1">ERG9 INTERNAL R</td><td style="text-align:left" rowspan="1" colspan="1">CTCGACACAGCCACGCAAAGTCC</td></tr><tr><td style="text-align:left" rowspan="1" colspan="1">gtmA RT-PCR F</td><td style="text-align:left" rowspan="1" colspan="1">TCCAGCGTACTCAACCACAC</td></tr><tr><td style="text-align:left" rowspan="1" colspan="1">gtmA RT-PCR R</td><td style="text-align:left" rowspan="1" colspan="1">CGTCTGGAAAGCTCTGGAA</td></tr></tbody></table></table-wrap><p>Growth analysis was carried out by diluting an overnight culture of cells in
fresh medium lacking leucine (-LEU) to an OD<sub>600</sub> = 0.2 and incubated
at 30&#x000b0;C shaking 200 rpm till an OD<sub>600</sub> = 0.4 was reached. Cells were
transferred to a microtiter plate and serially diluted. Cells were transferred
to &#x02013;LEU plates containing the desired concentration of GT (Sigma) using a
replicator and incubated at 30&#x000b0;C for 48 h, with further monitoring at room
temperature for 72 h.</p></sec><sec><title>RT-PCR</title><p>Total RNA was extracted from 5 mL cultures of the yeast strains grown overnight
at 30&#x000b0;C shaking 200 rpm. RNA was extracted using the QIAGEN RNeasy plant mini
kit as per manufacturers&#x02019; guidelines. RNA was DNase treated using DNase I kit
(Sigma-Aldrich), according to the manufacturer&#x02019;s recommendations. RNA
concentrations were measured using a Nano Drop 1000 Spectrophotometer (Mason
Technology).</p><p>cDNA was synthesized using the qScript<sup>TM</sup> cDNA Supermix (Quanta
Biosciences) as per manufacturer&#x02019;s instructions. Accu<italic>Taq </italic>LA
polymerase (Sigma) was used to amplify a housekeeping gene <italic>ERG9</italic>
as a control and the gene of interest <italic>gtmA.</italic> The primers used in
RT-PCR reactions are listed in Table 1. PCR reactions were conducted in a
PTC-200 Peltier Thermal Cycler (MJ Research) and the program consisted of 1
cycle of 95&#x000b0;C for 5 min, 35 cycles of 95&#x000b0;C for 30 sec, 58&#x000b0;C for 30 sec and 68&#x000b0;C
for 30 sec. Followed by a further cycle of 68&#x000b0;C for 10 min.</p></sec><sec><title>Mass spectrometry detection of gliotoxin and
<italic>bis</italic>-methylgliotoxin</title><p>GT uptake and BmGT conversion assays were carried out by diluting overnight cell
cultures in -LEU medium to an OD<sub>600</sub> = 0.4 and incubation at 30&#x000b0;C
shaking 200 rpm till an OD<sub>600</sub> = 1.2 was reached, followed by GT (5
&#x003bc;g/ml) addition and incubation for a further 3 h. Samples were taken every 30
min during the 3 h period, and were then centrifuged at 5,000 x g to obtain the
supernatant, which was then organically extracted using an equal volume of
chloroform. Organic extracts were dried to completion under a vacuum and
re-solubilized in methanol and analyzed by LC-MS (Agilent LC-MS system- Model
6340) as previously described <xref rid="B17" ref-type="bibr">17</xref>.</p></sec></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JR</given-names></name><name><surname>Bruce</surname><given-names>WF</given-names></name><name><surname>Dutcher</surname><given-names>JD</given-names></name></person-group><article-title>Gliotoxin, The Antibiotic Principle of Gliocladium
fimbriatum. I. Production, Physical and Biological Properties 1.</article-title><source>Journal of the
American Chemical Society</source><year>1943</year><volume>65</volume><issue>10</issue><fpage>2005</fpage><lpage>2009</lpage><pub-id pub-id-type="doi">10.1021/ja01250a051</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>DM</given-names></name><name><surname>Waring</surname><given-names>P</given-names></name><name><surname>Howlett</surname><given-names>BJ</given-names></name></person-group><article-title>The epipolythiodioxopiperazine (ETP) class of fungal toxins:
distribution, mode of action, functions and biosynthesis.</article-title><source>Microbiology</source><year>2005</year><volume>151</volume><issue>Pt 4</issue><fpage>1021</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1099/mic.0.27847-0</pub-id><pub-id pub-id-type="pmid">15817772</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>JJ</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Okoli</surname><given-names>I</given-names></name><name><surname>Mylonakis</surname><given-names>E</given-names></name></person-group><article-title>Antifungal activity of microbial secondary
metabolites.</article-title><source>PloS one</source><year>2011</year><volume>6</volume><issue>9</issue><fpage>e25321</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025321</pub-id><pub-id pub-id-type="pmid">21966496</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>DM</given-names></name><name><surname>Howlett</surname><given-names>BJ</given-names></name></person-group><article-title>Bioinformatic and expression analysis of the putative gliotoxin
biosynthetic gene cluster of Aspergillus fumigatus.</article-title><source>FEMS microbiology letters</source><year>2005</year><volume>248</volume><issue>2</issue><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.femsle.2005.05.046</pub-id><pub-id pub-id-type="pmid">15979823</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>DM</given-names></name><name><surname>Cozijnsen</surname><given-names>AJ</given-names></name><name><surname>Wilson</surname><given-names>LM</given-names></name><name><surname>Pedras</surname><given-names>MS</given-names></name><name><surname>Howlett</surname><given-names>BJ</given-names></name></person-group><article-title>The sirodesmin biosynthetic gene cluster of the plant pathogenic
fungus Leptosphaeria maculans.</article-title><source>Molecular microbiology</source><year>2004</year><volume>53</volume><issue>5</issue><fpage>1307</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04215.x</pub-id><pub-id pub-id-type="pmid">15387811</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Keeffe</surname><given-names>G</given-names></name><name><surname>Hammel</surname><given-names>S</given-names></name><name><surname>Owens</surname><given-names>RA</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Fitzpatrick</surname><given-names>DA</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>RNA-seq reveals the pan-transcriptomic impact of attenuating the
gliotoxin self-protection mechanism in Aspergillus
fumigatus.</article-title><source>BMC genomics</source><year>2014</year><volume>15</volume><fpage>894</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-15-894</pub-id><pub-id pub-id-type="pmid">25311525</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardo</surname><given-names>PH</given-names></name><name><surname>Brasch</surname><given-names>N</given-names></name><name><surname>Chai</surname><given-names>CL</given-names></name><name><surname>Waring</surname><given-names>P</given-names></name></person-group><article-title>A novel redox mechanism for the glutathione-dependent reversible
uptake of a fungal toxin in cells.</article-title><source>The Journal of biological chemistry</source><year>2003</year><volume>278</volume><issue>47</issue><fpage>46549</fpage><lpage>46555</lpage><pub-id pub-id-type="doi">10.1074/jbc.M304825200</pub-id><pub-id pub-id-type="pmid">12947114</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waring</surname><given-names>P</given-names></name><name><surname>Beaver</surname><given-names>J</given-names></name></person-group><article-title>Gliotoxin and related
epipolythiodioxopiperazines.</article-title><source>General pharmacology</source><year>1996</year><volume>27</volume><issue>8</issue><fpage>1311</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1016/S0306-3623(96)00083-3</pub-id><pub-id pub-id-type="pmid">9304400</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>DH</given-names></name><name><surname>Remme</surname><given-names>N</given-names></name><name><surname>Heinekamp</surname><given-names>T</given-names></name><name><surname>Hortschansky</surname><given-names>P</given-names></name><name><surname>Brakhage</surname><given-names>AA</given-names></name><name><surname>Hertweck</surname><given-names>C</given-names></name></person-group><article-title>Transannular disulfide formation in gliotoxin biosynthesis and
its role in self-resistance of the human pathogen Aspergillus
fumigatus.</article-title><source>Journal of the American Chemical Society</source><year>2010</year><volume>132</volume><issue>29</issue><fpage>10136</fpage><lpage>10141</lpage><pub-id pub-id-type="doi">10.1021/ja103262m</pub-id><pub-id pub-id-type="pmid">20593880</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrettl</surname><given-names>M</given-names></name><name><surname>Carberry</surname><given-names>S</given-names></name><name><surname>Kavanagh</surname><given-names>K</given-names></name><name><surname>Haas</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>O'Brien</surname><given-names>J</given-names></name><name><surname>Nolan</surname><given-names>A</given-names></name><name><surname>Stephens</surname><given-names>J</given-names></name><name><surname>Fenelon</surname><given-names>O</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>Self-protection against gliotoxin--a component of the gliotoxin
biosynthetic cluster, GliT, completely protects Aspergillus fumigatus
against exogenous gliotoxin.</article-title><source>PLoS pathogens</source><year>2010</year><volume>6</volume><issue>6</issue><fpage>e1000952</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000952</pub-id><pub-id pub-id-type="pmid">20548963</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>SK</given-names></name><name><surname>O'Keeffe</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>Resistance is not futile: gliotoxin biosynthesis, functionality
and utility.</article-title><source>Trends in microbiology</source><year>2015</year><volume>23</volume><issue>7</issue><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2015.02.005</pub-id><pub-id pub-id-type="pmid">25766143</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carberry</surname><given-names>S</given-names></name><name><surname>Molloy</surname><given-names>E</given-names></name><name><surname>Hammel</surname><given-names>S</given-names></name><name><surname>O'Keeffe</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Kavanagh</surname><given-names>K</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>Gliotoxin effects on fungal growth: mechanisms and
exploitation.</article-title><source>Fungal genetics and biology : FG &#x00026; B</source><year>2012</year><volume>49</volume><issue>4</issue><fpage>302</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2012.02.003</pub-id><pub-id pub-id-type="pmid">22405895</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamilos</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>RE</given-names></name><name><surname>Lamaris</surname><given-names>GA</given-names></name><name><surname>Albert</surname><given-names>ND</given-names></name><name><surname>Kontoyiannis</surname><given-names>DP</given-names></name></person-group><article-title>Genomewide screening for genes associated with gliotoxin
resistance and sensitivity in Saccharomyces cerevisiae.</article-title><source>Antimicrobial agents and chemotherapy</source><year>2008</year><volume>52</volume><issue>4</issue><fpage>1325</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1128/AAC.01393-07</pub-id><pub-id pub-id-type="pmid">18212113</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>SK</given-names></name><name><surname>Owens</surname><given-names>RA</given-names></name><name><surname>O'Keeffe</surname><given-names>G</given-names></name><name><surname>Hammel</surname><given-names>S</given-names></name><name><surname>Fitzpatrick</surname><given-names>DA</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>Regulation of nonribosomal peptide synthesis: bis-thiomethylation
attenuates gliotoxin biosynthesis in Aspergillus fumigatus.</article-title><source>Chemistry &#x00026; biology</source><year>2014</year><volume>21</volume><issue>8</issue><fpage>999</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2014.07.006</pub-id><pub-id pub-id-type="pmid">25126990</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>DH</given-names></name><name><surname>Habel</surname><given-names>A</given-names></name><name><surname>Heinekamp</surname><given-names>T</given-names></name><name><surname>Brakhage</surname><given-names>AA</given-names></name><name><surname>Hertweck</surname><given-names>C</given-names></name></person-group><article-title>Opposed effects of enzymatic gliotoxin N- and
S-methylations.</article-title><source>Journal of the American Chemical Society</source><year>2014</year><volume>136</volume><issue>33</issue><fpage>11674</fpage><lpage>11679</lpage><pub-id pub-id-type="doi">10.1021/ja5033106</pub-id><pub-id pub-id-type="pmid">25062268</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Forseth</surname><given-names>RR</given-names></name><name><surname>Bowers</surname><given-names>AA</given-names></name><name><surname>Schroeder</surname><given-names>FC</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name></person-group><article-title>A backup plan for self-protection: S-methylation of holomycin
biosynthetic intermediates in Streptomyces clavuligerus.</article-title><source>Chembiochem : a European journal of chemical biology</source><year>2012</year><volume>13</volume><issue>17</issue><fpage>2521</fpage><lpage>2526</lpage><pub-id pub-id-type="doi">10.1002/cbic.201200536</pub-id><pub-id pub-id-type="pmid">23097183</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>RA</given-names></name><name><surname>O'Keeffe</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>EB</given-names></name><name><surname>Dolan</surname><given-names>SK</given-names></name><name><surname>Hammel</surname><given-names>S</given-names></name><name><surname>Sheridan</surname><given-names>KJ</given-names></name><name><surname>Fitzpatrick</surname><given-names>DA</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>Interplay between Gliotoxin Resistance, Secretion, and the
Methyl/Methionine Cycle in Aspergillus fumigatus.</article-title><source>Eukaryotic cell</source><year>2015</year><volume>14</volume><issue>9</issue><fpage>941</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1128/EC.00055-15</pub-id><pub-id pub-id-type="pmid">26150413</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loovers</surname><given-names>HM</given-names></name><name><surname>Guinan</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name></person-group><article-title>Importance of the Hsp70 ATPase domain in yeast prion
propagation.</article-title><source>Genetics</source><year>2007</year><volume>175</volume><issue>2</issue><fpage>621</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1534/genetics.106.066019</pub-id><pub-id pub-id-type="pmid">17151238</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>RA</given-names></name><name><surname>Hammel</surname><given-names>S</given-names></name><name><surname>Sheridan</surname><given-names>KJ</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>A proteomic approach to investigating gene cluster expression and
secondary metabolite functionality in Aspergillus fumigatus.</article-title><source>PloS one</source><year>2014</year><volume>9</volume><issue>9</issue><fpage>e106942</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0106942</pub-id><pub-id pub-id-type="pmid">25198175</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzanares-Miralles</surname><given-names>L</given-names></name><name><surname>Sarikaya-Bayram</surname><given-names>&#x000d6;</given-names></name><name><surname>Smith</surname><given-names>EB</given-names></name><name><surname>Dolan</surname><given-names>SK</given-names></name><name><surname>Bayram</surname><given-names>&#x000d6;</given-names></name><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name></person-group><article-title>Quantitative proteomics reveals the mechanism and consequence of
gliotoxin-mediated dysregulation of the methionine cycle in Aspergillus
niger.</article-title><source>Genetics</source><year>2016</year><volume>10</volume><issue>131</issue><fpage>149</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2015.10.024</pub-id></element-citation></ref></ref-list></back></article>